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DIABETES
Can diabetes management be safely transferred to practice nurses in a
primary care setting? A randomised controlled trial
Sebastiaan T Houweling, Nanne Kleefstra, Kornelis JJ van Hateren, Klaas H Groenier, Betty Meyboom-
de Jong and Henk JG Bilo
Aims and objectives. To determine whether the management of type 2 diabetes mellitus in a primary care setting can be safely
transferred to practice nurses.
Background. Because of the increasing prevalence of type 2 diabetes mellitus and the burden of caring for individual patients,
the demand type 2 diabetes mellitus patients place on primary health care resources has become overwhelming.
Design. Randomised controlled trial.
Methods. The patients in the intervention group were cared for by practice nurses who treated glucose levels, blood pressure
and lipid profile according to a specified protocol. The control group received conventional care from a general practitioner. The
primary outcome measure was the mean decrease seen in glycated haemoglobin (HbA1c) levels at the end of the follow-up
period (14 months).
Results. A total of 230 patients was randomised with 206 completing the study. The between-group differences with respect to
reduction in HbA1c, blood pressure and lipid profile were not significant. Blood pressure decreased significantly in both groups;
7Æ4/3Æ2 mm Hg in the intervention group and 5Æ6/1Æ0 mm Hg in the control group. In both groups, more patients met the target
values goals for lipid profile compared to baseline. In the intervention group, there was some deterioration in the health-related
quality of life and an increase in diabetes-related symptoms. Patients being treated by a practice nurse were more satisfied with
their treatment than those being treated by a general practitioner.
Conclusion. Practice nurses achieved results, which were comparable to those achieved by a general practitioner with respect to
clinical parameters with better patient satisfaction.
Relevance to clinical practice. This study shows that diabetes management in primary care can be safely transferred to practice
nurses.
Key words: nurses, nursing, randomised controlled trial, type 2 diabetes mellitus
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Introduction
Type 2 diabetes mellitus (T2DM) is a chronic, progressive
disorder, which causes considerable morbidity and mortality
(Kannel & McGee 1979, Nathan et al. 1997). The world-
wide prevalence of T2DM is high and is still increasing
(Wild et al. 2004, Baan et al. 2009). In The Netherlands, more
than 700,000 patients (4% of the population) currently have
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a diagnosis of diabetes, and this number will increase to 1Æ3
million patients by 2025 (Baan et al. 2009). With an
estimated total population of 16Æ9 million people in 2025,
almost 8% of the population will have diabetes. Worldwide,
the total number of patients with diabetes is projected to rise
from 171 million in 2000 (2Æ8%) to 366 million in 2030
(4Æ4%) (Wild et al. 2004). The development of new measures
to lower the risk of cardiovascular disease has become
increasingly important over the past decades. Accordingly,
the current guidelines for the treatment of T2DM emphasise
the aggressive treatment of important cardiovascular risk
factors such as hypertension and dyslipidemia (Rutten et al.
2006). Because of the increasing prevalence and the burden of
caring for individual patients, the demand T2DM patients
place on primary health care resources has become over-
whelming. This led to the consideration of transferring
certain tasks, previously performed exclusively by physicians,
to other medical professionals such as practice nurses (PNs).
Approximately 62% of general practices in The Netherlands
presently employ PNs (Hingstman & Kenens 2007). One of
their main tasks is caring for patients with diabetes mellitus
(Houweling et al. 2006, Meulepas et al. 2006, Van den Berg
& Simkens 2006, Van Avendonk et al. 2007). The Nether-
lands has not expanded the scope of nurses as much as has
been carried out in some countries such as the UK, the USA
and Sweden, where nurses are permitted to prescribe
medications (Kuebler 2003, Wilhelmsson & Foldevi 2003,
Latter & Courtenay 2004). Dutch law does not allow nurses
to write prescriptions. Although diabetes care has become
highly dependant on PNs nowadays, only a few quality of
care comparison studies have been conducted in The Neth-
erlands. With this study, we wanted to test the hypothesis
that the management of T2DM in a primary care setting can
be safely transferred to PNs, without compromising the
quality of clinical care, health-related quality of life
(HRQOL) or patient satisfaction.
Methods
Study design
This study was a pragmatic randomised controlled trial
to investigate the effects of transferring diabetes care to PNs
in a primary care setting.
Sampling
All participants in this study were patients with T2DM from
a group practice with five general practitioners (GPs) in the
north-east region of The Netherlands. Eligible patients were
selected using the GPs’ patient information system and the
local pharmacy. The initial selection included patients with a
diagnosis of diabetes, patients who were on medication for
diabetes and patients whose glycated haemoglobin (HbA1c)
levels had been measured in the last three years. The
exclusion criteria included (1) no diagnosis of diabetes,
(2) type 1 diabetes, (3) diabetes not being treated in the
primary health care setting, (4) the inability to participate in
the study because of old age or comorbidity, in the opinion of
the GP and (5) not being willing to return for follow-up.
Intervention and control group
The patients in the intervention group were primarily treated
by two PNs, who were both PNs without any special training
in the treatment of diabetes prior to the start of this trial. At
the beginning of the trial, the PNs received one week of
training on a detailed treatment and management protocol
aimed at optimising glucose, blood pressure and lipid profile
regulation and eye and foot care in patients with diabetes
(Houweling et al. 2004). The training aimed to educate the
PNs to a level comparable to the level of a GP, so they would
be able to provide diabetes care without supervision. The
protocol was based on the guidelines published by the Dutch
College of General Practitioners and on those from the Dutch
Diabetes Federation (Rutten et al. 1999, Dutch Diabetes
Federation 2000). For the purposes of this trial, the PNs were
permitted to prescribe 14 different medications and to adjust
dosages for a further 30. They were also allowed to order
laboratory tests. The PNs were specifically not permitted to
prescribe insulin, but were able to adjust the dosage. The
control group received standard care from a GP. If the
initiation of insulin therapy was indicated in any patient in
either group, he or she was referred to an internist.
Primary and secondary outcome measures
The primary endpoint was the mean decrease seen in HbA1c
levels at follow-up compared with baseline. Secondary
endpoints were blood pressure, cholesterol and cholesterol/
high density lipoprotein (HDL)-ratio, proportion of patients
achieving target ranges of glycaemic control (HbA1c below
7% and 8Æ5%, respectively), blood pressure (below 140/
90 mmHg) and lipid profile (variable, depending on total
cardiovascular risk and recommendations according to
primary or secondary prevention). The following indicators
were also looked at the proportion of patients: (1) referred to
an ophthalmologist after not having visited one for the last
two years, (2) in whom measures were taken for feet at-risk,
(3) referred to an internist for starting insulin therapy,
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(4) whose diabetic, antihypertensive and/or lipid lowering
drugs had been intensified. Other secondary endpoints
included measures of HRQOL, diabetes-related symptoms,
patients’ satisfaction and health care consumption (number
of patient visits, number of contacts between PNs and GP).
Measures
All subjects were seen prior to any intervention, before being
randomly assigned to one of the two study groups and after
14 months (T2). The duration of T2DM, any diabetes
medication(s), general medication(s) and the date of the last
retina control were recorded at baseline. The patients were
weighed clothed without shoes. Height was measured with-
out shoes, and blood pressure was measured with the patient
in a sitting position. Initially, blood pressure was measured
twice in both arms, with an interval between measurements
of at least 15 seconds. The mean of the two blood pressure
readings was calculated for each arm. When there was a
difference of more than 10 mmHg between the systolic and/
or the diastolic blood pressures, the blood pressure during
follow-up was measured in the arm with the highest blood
pressure. When the difference was less than 10 mmHg, either
arm could be used for the measurements at T2. A calibrated
and validated Omron M5-I (HEM-757) automatic blood
pressure device was used to measure blood pressure (El
Assaad et al. 2003). To assess the risk of developing diabetic
foot symptoms, both the dorsalis pedis artery and the
posterior tibial artery were palpated and sensibility was
tested using Semmes Weinstein monofilaments. HbA1c,
serum total cholesterol, low-density lipoprotein, HDL, tri-
glycerides, alanine aminotransferase and creatinine levels
were measured according to standard hospital procedures.
HRQOL was assessed with the Short Form 36 questionnaire
(SF-36). The SF-36 is a validated generic HRQOL question-
naire that includes both mental and physical factors (Ware &
Sherbourne 1992, Aaronson et al. 1998). To measure the
presence and the perceived burden of diabetes-related symp-
toms, the revised version of the type 2 Diabetes Symptom
Checklist (DSC-type 2) was used (Grootenhuis et al. 1994).
Satisfaction with diabetes care was assessed using the
Patients’ Evaluation of the Quality of Diabetes Care (PEQD)
(Pouwer & Snoek 2002). Patients in the GP group were asked
about the number of visits. This number was multiplied by
10 minutes, which is the standard average time the five GPs
scheduled for each of their patients, to estimate the total
duration of the visits. In the intervention group, similar
information was recorded by the involved PN. The PNs also
kept records of the number and duration of consultations
with the GP.
Randomisation and sample size power
Eligible patients were informed by their GP or PN about the
study. Patients willing to participate were then randomised
by two independent medical investigators (STH and NK).
The patient population was randomised using non-transpar-
ent, closed envelopes containing sequential numbers. Subjects
with even numbers were assigned to the intervention group,
and those with odd numbers were assigned to the control
group. Two hundred and sixteen patients were required for
the detection of a 0Æ5%-point difference in mean HbA1c
between groups at T2 with a power of 80%, alpha 5% (two-
sided) and an assumed standard deviation of 1Æ3. This
calculation was based on the mean HbA1c of patients in
the primary care health system in the Zwolle region (7Æ5%,
SD 1Æ3) (Ubink-Veltmaat et al. 1995).
Statistical analyses
Statistical analyses were performed using SPSS 15Æ0 (SPSS Inc.,
Chicago, IL, USA) forWindows. For longitudinal analyses, the
general linear model (GLM repeated measures) for continuous
variables and the McNemar test for changes in dichotomous
variables were used. To study changes in HRQOL, diabetes-
related symptoms and quality of diabetes care, we used the
Mann–Whitney U tests for analyses between groups and the
Wilcoxon signed rank tests for changes from baseline within
groups because of some skewed outcomes. The internal
consistency of the item scores was assessed using Cronbach’s
alpha (Cronbach 1951); reported p-values are two tailed.
Ethical considerations
The Medical Ethics Committee of the Isala Clinics, Zwolle,
The Netherlands concluded that this study did not need
formal approval, because they had previously approved a
study with a similar design performed in the secondary health
care setting (Houweling et al. 2009). All patients gave written
informed consent, and all data were analysed anonymously.
Results
Figure 1 shows the number of participants involved through-
out the study. After the assessment of eligibility, 133 patients
were excluded because of treatment by an internist (n = 76),
no diagnosis of diabetes (n = 26), old age or comorbidity
(n = 21) and unwillingness to participate (n = 10). Of the
230 randomised patients, 24 patients were lost to follow-up
(14 in the intervention group and 10 in the control group).
A total of 206 patients, 102 in the intervention group and
ST Houweling et al.
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104 in the control group were used for analysis. The groups
were comparable with respect to age, gender, T2DM dura-
tion, body mass index (BMI), blood pressure, HbA1c and
lipid profile (Table 1). However, more patients in the PN
group had feet at-risk compared to the GP group.
After a follow-up of 14 months, the mean systolic and
diastolic blood pressures were significantly lower in both
groups (Table 2). The mean BMI (95% confidence interval)
significantly declined in the control group with 0Æ3 kg/m2
(0Æ1–0Æ6). The other outcome indicators did not change, and
any differences between the groups were not significant. In
addition, the proportion of patients meeting the predefined
blood pressure goal of <140 mmHg systolic significantly
increased in the PN group (Table 3). In both groups, more
patients met the target values goals for lipid profile when
compared to the data obtained at baseline. The differences
between the groups were not significant.
Table 4 presents the process indicators in both treatment
groups. Patients who had their last retina control more than
two years ago were referred to the ophthalmologist in 70Æ6%
of all cases by the PNs, compared to 36Æ7% by the GPs
(p = 0Æ007). Measures to prevent the development of diabetic
foot symptoms were taken in 56Æ7% of the feet at-risk cases
in the PN group and in 26Æ5% in the GP group (p = 0Æ001).
The PNs referred more patients to the internist for the
initiation of insulin therapy than the GPs (p = 0Æ015). The
PNs generally stepped up the treatment for hypertension and
diabetes, whereas the GPs more often targeted the lipid
profile. However, the difference in lipid treatment between
the groups was not significant.
At both baseline and follow-up, 178 patients (86%)
completed the SF-36, 168 patients (82%) completed the
Diabetes Symptom Checklist and 179 patients (87%) com-
pleted the satisfaction survey. There were no significant
differences between the baseline and follow-up results for all
of the HRQOL items (SF-36) reported by the subjects in the
control group (Table 5). In the PN group, four areas were
adversely affected: physical functioning, role physical, vitality
and the physical component score. No differences were seen
in the HRQOL results over time between the two groups,
except for the Physical Component Score which was lower in
the intervention group. In both groups, significant differences
were found at follow-up for some of the Diabetes Symptom
Score dimensions (data not shown). After 14 months, the
mean ‘fatigue’ and ‘cognitive distress’ sub-dimension scores
and the total score were lower in each group, although
no difference was seen between the groups. The internal
Figure 1 Flow diagram. Number of participants in stages of the trial.
Table 1 Baseline characteristics
PN GP
Gender (male) 54/102 (52Æ9) 44/104 (42Æ3)
Age (year) 67Æ1 ± 11Æ0 69Æ5 ± 10Æ6
Diabetes duration (year) (mean ± SD,
median (25%–75%)
7Æ2 ± 6Æ6 6Æ0 (2Æ0–10Æ0) 7Æ8 ± 7Æ3 5Æ0 (3Æ0–13Æ0)
Percentage patients with last retina control
>24 months ago
36/102 (35Æ3) 30/102 (29Æ4)
Percentage patients with feet at-risk 64/101 (63Æ4) 50/102 (49Æ0)
Body mass index (kg/m2) 30Æ6 ± 5Æ3 30Æ3 ± 4Æ5
Systolic blood pressure (mmHg) 157Æ5 ± 20Æ4 161Æ3 ± 24Æ8
Diastolic blood pressure (mmHg) 87Æ2 ± 10Æ7 87Æ0 ± 11Æ2
HbA1c (%) 7Æ6 ± 1Æ3 7Æ4 ± 1Æ3
Total cholesterol (mmol/l) 5Æ4 ± 1Æ1 5Æ4 ± 1Æ0
Cholesterol/HDL ratio 4Æ4 ± 1Æ1 4Æ1 ± 1Æ2
Data are absolute numbers (%) or mean ± SD unless stated otherwise.
GP, general practitioner; HDL, high density lipoprotein; PN, practice nurse.
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consistency of the 14 PEQD items was high with a
Cronbach’s alpha of 0Æ97. The total satisfaction sum score
for the PNs was 66Æ4% and for the GPs 51Æ7%.
The mean number of visits was 6Æ1 in the PN group and 2Æ8
in the GP group (p < 0Æ001). As a consequence, the total
duration of the visits was also significantly higher in the PN
group. In some cases, the protocol being followed by the PN
indicated that consultation with a GP was necessary. The
median number of these consultations per patient was 1Æ4
(25–75 quartiles: 0Æ0–2Æ0) with a median time of 1Æ0 (25–75
quartiles: 0Æ0–3Æ3) minute.
Discussion
This is the first randomised controlled study where the care
provided by a PN, with an almost complete shift of diabetes
care, is compared with care provided by a GP in a population
of patients with T2DM in the primary health care setting in
The Netherlands. The results show that a nurse, when
following specific guideline protocols, achieves results which
are comparable to those achieved by a GP with respect to
blood pressure, glucose and lipid profile regulation. Further-
more, most of the results regarding the process indicators
were remarkably better in the group cared for by a nurse.
Although patients in the PN group were more satisfied with
the care they received than the patients in the control
group, the physical component summary of the SF-36 was
better in the GP group.
The deterioration of the SF-36 physical component scores
seen in the PN group, compared with the GP group, was
unexpected and has not previously been described in the
literature. Although it was not a separate health dimension
that got worse in the PN group compared to the GP group,
but only a component summary suggesting an overall
direction of the ‘physical’ quality of life, it is interesting to
speculate about the underlying cause. It is possible that
participating in this study forced the patients to focus more
on their diabetes. Perhaps, they became more aware of the
complications of diabetes in the long term with its physical
consequences. Because patients in the intervention group
visited their care provider (the PNs) more often and for
longer periods of time, the effects are probably more
pronounced in this group. Further investigation is necessary
to answer the question of whether the potential negative
effects on HRQOL are caused by the PNs providing the
treatment or whether it is a temporary phenomenon.
Confounding factors may contribute to the explanation for
the differences seen between the groups with respect to
treatment satisfaction and the process indicators. An impor-
tant confounder is probably the amount of time given to each
patient. The mean number of patient visits was 6Æ1 in the PN
group vs. 2Æ8 in the GP group (p < 0Æ001), and a PN visit
lasted an average of 21 minutes compared with 10 minutes





T2 (95% CI) Baseline
Mean paired difference
T2 (95% CI)
Systolic BP (mmHg) 157Æ5 ± 20Æ4 7Æ4 (3Æ8,10Æ9) 161Æ3 ± 24Æ8 5Æ6 (2Æ3, 8Æ8) 0Æ122
Diastolic BP (mmHg) 87Æ2 ± 10Æ7 3Æ2 (1Æ3, 5Æ2) 87Æ0 ± 11Æ2 1Æ0 (0Æ8, 2Æ8) 0Æ391
BMI (kg/m2) 30Æ6 ± 5Æ3 0Æ2 (0Æ5,0Æ1) 30Æ3 ± 4Æ5 0Æ3 (0Æ6, 0Æ1) 0Æ377
HbA1c (%) 7Æ6 ± 1Æ3 0Æ09 (0Æ3,0Æ1) 7Æ4 ± 1Æ3 0Æ03 (0Æ2,0Æ3) 0Æ423
Total cholesterol (mmol/l) 5Æ4 ± 1Æ1 0Æ1 (0Æ3,0Æ1) 5Æ4 ± 1Æ0 0Æ05 (0Æ2,0Æ1) 0Æ321
Cholesterol/HDL 4Æ4 ± 1Æ1 0Æ03 (0Æ1,0Æ2) 4Æ1 ± 1Æ2 0Æ07 (0Æ1,0Æ2) 0Æ385
BMI, body mass index; GP, general practitioner; HDL, high density lipoprotein; PN, practice nurse.
Table 3 Per cent of patients meeting target values
Goal
PN GP








































Data are absolute numbers (%).
GP, general practitioner; PN, practice nurse.
*Individual target values according to Dutch guidelines in which an
indication for treatment in men between 50–70 years of age and
women between 50–75 years of age with a 25% chance of devel-
oping cardiovascular disease in 10 years. During treatment, the target
value for the cholesterol level is <5 mmol/l.
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for a GP visit. On average, GPs spent a total of 28 minutes
per patient during the study period of 14 months, whereas
the PNs spent a total of 128 minutes. Treatment satisfaction
is surely to be influenced by the amount of time spent by the
health care provider. Furthermore, PNs had more time with
their patients to achieve the treatment goals, and patients
probably had more time to ask questions and discuss any
difficulties they encountered in their diabetes treatment.
Another explanation may be that PNs tended to follow the
protocol more strictly than the GPs. Take for example blood
pressure management. In patients with a blood pressure
>140/90 at baseline, blood pressure lowering treatment was




Patients with last retina control >24 months ago (n = 64) referred to an
ophthalmologist
24/34 (70Æ6) 11/30 (36Æ7) 0Æ007
Patients with feet at-risk (n = 109) in whom measures were taken 34/60 (56Æ7) 13/49 (26Æ5) 0Æ001
Patients referred to an internist for starting insulin therapy 10/102 (9Æ8) 2/104 (1Æ9) 0Æ015
Patients with a HbA1c ‡7 at baseline (n = 120), in whom glucose lowering
therapy was intensified
53/64 (82Æ8) 28/56 (50Æ0) <0Æ001
Patients with a BP >140/90 at baseline (n = 170) in whom blood pressure
lowering therapy was intensified
42/85 (49Æ4) 24/85 (28Æ2) 0Æ005
Patients not meeting the target values for lipid profile at baseline (n = 55),
in whom lipid lowering therapy was intensified
13/29 (44Æ8) 13/26 (50Æ0) 0Æ147
Data are absolute numbers (%).
GP, general practitioner; PN, practice nurse.












































































































0 (worst health) to 100 (best health).
General linear model between groups NS for all variables, except for physical component score: p = 0Æ040.
GP, general practitioner; PN, practice nurse.
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intensified in 49Æ4% in the PN group compared to 28Æ2% in
the GP group (p = 0Æ005). Perhaps, PNs aggressively inten-
sified blood pressure lowering therapy even in patients with
only mildly elevated blood pressure levels, where GPs in the
same situation may initially have opted for a wait-and-see
policy.
Except for the possibility of confounding, our study has
some other limitations. First of all, the required sample size to
detect a 0Æ5%-point difference in HbA1c was a total of 216
patients. Unfortunately, we only have a complete follow-up
of 206 patients. However, the difference in HbA1c (95%
confidence interval) between groups after 14 months was
0Æ042% (0Æ207;0Æ265). As the confidence interval does not
include the possibility of a 0Æ5%-point difference in HbA1c
between groups, we are able to make the conclusions as
hypothesised. Second, the outcome assessors of the clinical
variables (such as blood pressure) were not blinded to the
intervention. For obvious reasons, blinding of the patients
and care providers was not possible in our study.
Task delegation of diabetes management in primary health
care has been investigated by Vrijhoef and van Son in The
Netherlands (Vrijhoef et al. 2001, Van Son et al. 2004).
However, nurses were not allowed to start or adjust
medication in these studies. A Cochrane review from 2003
investigated the effect on the metabolic regulation of patients
with diabetes when treatment was carried out by a nurse
(Loveman et al. 2003). Only six studies were included in this
review. Three of the studies in the review included patients
with type 1 diabetes in a hospital setting. In the other three
studies, the nurse was responsible only for delivering treat-
ment recommendations to the primary physician, without
being responsible for treating the patient. All the studies
performed prior to 2002 were included in the Cochrane
review.
In addition to this review, we discovered seven randomised
studies in Medline, which were published between 2002–
2009 (Davies et al. 2001, Davidson 2003, Gary et al. 2003,
New et al. 2003, Taylor et al. 2003, Tobe et al. 2006,
Cleveringa et al. 2008). Nurses were allowed to titrate
medications according to an algorithm in three of the studies
(Davidson 2003, Taylor et al. 2003, Tobe et al. 2006). The
results when the treatment was administered by a nurse were
comparable or superior to the results for patients receiving
standard care from the GP. Although Tobe et al. selected
primary care patients, the home care nurses involved were
indirectly supervised by a specialist in hypertension (Tobe
et al. 2006). Patients in the study by New et al. all received
shared care at baseline and are therefore not representative of
typical type 2 diabetic populations in the primary health care
setting (New et al. 2003). The study by Taylor et al. is
therefore the only one which involved patients in the primary
health care setting (Taylor et al. 2003). The nurses in Taylor
et al.’s study were not permitted to prescribe new medication.
More recently, another study was performed in The Nether-
lands (Cleveringa et al. 2008). This study investigated the
effect of the Diabetes Care Protocol on HbA1c and cardio-
vascular risk factors. The Diabetes Care Protocol combines
task delegation (PN), computerised decision support and
feedback every 3 months. Changes in treatment were only
performed by the PNs after they were approved by the GP.
Relevance to clinical practice
In most published studies about nurse care management, the
objective is to determine whether care provided by a nurse
would lead to improved care for patients with diabetes. The
question being considered in this study was not whether or
not care delivered by a nurse would be better than care
delivered by a GP, but whether such care would at least be
comparable to the care provided by a GP. Furthermore,
nurses were allowed to prescribe medication for the purposes
of our study. Our results show that standardised care
delivered by a specially trained nurse is a good alternative
to standard care by a GP, as the short-term results with
respect to the standard medical parameters were comparable
and patient satisfaction was actually better when patients
were treated by a nurse. We would like to recommend that
PNs should be allowed to prescribe medications in The
Netherlands, as is common practice in some other countries.
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